1. Using external reference pricing in Medicare Part D to reduce drug price differentials with other countries.;Health Affairs,2019
2. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.;Health Affairs,2013
3. Paying for prescription drugs around the world: Why is the U.S. an outlier?;Issue Brief (Commonwealth Fund),2017
4. 4. Rimer, B.K. 2018. “The imperative of addressing cancer drug costs and value.” National Cancer Institute. Accessed June 12, 2020. https://www.cancer.gov/news-events/cancer-currents-blog/2018/presidents-cancer-panel-drug-prices
5. 5. Langreth, R. 2019. “Drug prices.” Bloomberg. Accessed June 12, 2020. https://www.bloomberg.com/quicktake/drug-prices